Androgen deprivation exacerbates AD pathology by promoting the loss of microglia in an age-dependent manner

• DOI: 10.1016/j.lfs.2024.122973
• Publication Date: 2024-08-12T21:33:55Z
• Authors: Jiaxin Cao; Haichao Chen; Yishu Zhang; Yiting Kang; Siwei Zhou; Zirui Liao; Liping Gao; Jie Yin; Yuhong Jing
• Keywords: Male; Amyloid beta-Peptides; Age Factors; Mice, Transgenic; Dihydrotestosterone; Apoptosis; Plaque, Amyloid; Hippocampus; Mice, Inbred C57BL; Mice; Disease Models, Animal; Alzheimer Disease; Androgens; Animals; Microglia; Orchiectomy; Cell Proliferation

Microglial cells are integral to the pathogenesis of Alzheimer's disease (AD). The observed sex disparity in AD prevalence, with a notable predominance in women, implies a potential influence of sex hormones, such as androgens, on disease mechanisms. Despite this, the specific effects of androgens on microglia remain unclear. This study is designed to delineate the interplay between androgens and the survival and inflammatory profile of microglial cells, as well as to explore their contribution to the progression of AD.To create a chronic androgen deficiency model, 3-month-old wild-type (WT) mice and APP/PS1 mice underwent bilateral orchiectomy (ORX), with age-matched sham-operated controls. Cognitive and memory were evaluated at 5 and 12 months, paralleled by assessments of amyloid-beta (Aβ) and microglial morphology in hippocampal and cortical areas. The ORX treatment in mice resulted in diminished microglial populations and morphological alterations, alongside an increase in Aβ plaques and a concomitant decline in cognitive performance that exacerbated over time. In vitro, dihydrotestosterone (DHT) was found to stimulate microglial proliferation and ameliorate Aβ1-42-induced apoptosis.These findings suggested that androgens may exert a protective role, maintaining the normal proliferation and functionality of microglial cells. This preservation could potentially slow the progression of AD. As a result, our study provided a conceptual framework for the development of novel therapeutic strategies for AD.